SANGAMO THERAPEUTICS INC (SGMO)

US8006771062 - Common Stock

0.491  -0.03 (-5.74%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
176.23M111.30M110.70M118.20M102.40M
Minority Interest Expense
0.000.000.00100.00K200.00K
Operating Expenses
278.82M312.60M294.00M247.70M207.60M
Research and Development
221.66M249.90M230.80M180.60M145.90M
Selling, General, and Administrative Expenses
57.17M62.70M63.20M67.10M61.70M
Operating Income
-102.59M-201.30M-183.30M-129.60M-105.20M
Interest Income/Expense
11.10M9.40M5.30M8.80M9.80M
Non Recurring Items
-171.41MN/AN/AN/AN/A
Income Before Taxes
-262.90M-191.80M-178.00M-120.80M-95.40M
Income Tax
-5.07M400.00K300.00K300.00K0.00
Net Income
-257.83M-192.30M-178.30M-121.00M-95.20M
EBITDA
-87.53M-189.20M-173.90M-123.90M-95.60M
 
Per Share Data
EPS Diluted Total Ops
-1.48-1.25-1.23-0.90-0.85
Non GAAP EPS
-1.47-1.25-1.24-0.93-0.84
 
Statistics
Profit Margin
-146.30%-172.78%-161.07%-102.37%-92.97%
Operating Profit Margin
-58.21%-180.86%-165.58%-109.64%-102.73%

All data in USD

Charts